{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T14:17:16Z","timestamp":1791209836107,"version":"4.1.0"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","prd-journal.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Parkinsonism & Related Disorders"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.parkreldis.2017.02.025","type":"journal-article","created":{"date-parts":[[2017,2,22]],"date-time":"2017-02-22T19:16:53Z","timestamp":1487791013000},"page":"4-16","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Parkinsonian-Pyramidal syndromes: A systematic review"],"prefix":"10.1016","volume":"39","author":[{"given":"Christine","family":"Tranchant","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meriam","family":"Koob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathieu","family":"Anheim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.parkreldis.2017.02.025_bib1","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1097\/00005072-195401000-00007","article-title":"Pallido-pyramidal disease","volume":"13","author":"Davidson","year":"1954","journal-title":"J.\u00a0Neuropathol. Exp. Neurol."},{"issue":"9","key":"10.1016\/j.parkreldis.2017.02.025_bib2","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1002\/mds.23118","article-title":"Pallidopyramidal disease: a misnomer?","volume":"25","author":"Horstink","year":"2010","journal-title":"Mov. Disord."},{"issue":"7","key":"10.1016\/j.parkreldis.2017.02.025_bib3","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1093\/brain\/awu121","article-title":"Overlapping phenotypes in complex spastic paraplegias SPG11, SPG15, SPG35 and SPG48","volume":"137","author":"Pensato","year":"2014","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.parkreldis.2017.02.025_bib4","first-page":"104","article-title":"SPG11 spastic paraplegia. A new cause of juvenile parkinsonism","volume":"256","author":"Anheim","year":"2009","journal-title":"J.\u00a0Neurol."},{"issue":"2","key":"10.1016\/j.parkreldis.2017.02.025_bib5","first-page":"435","article-title":"SPG15: a cause of juvenile atypical levodopa responsive parkinsonism","volume":"261","author":"Mallaret","year":"2014","journal-title":"J.\u00a0Neurol."},{"issue":"10","key":"10.1016\/j.parkreldis.2017.02.025_bib6","doi-asserted-by":"crossref","first-page":"3119","DOI":"10.1093\/brain\/awt227","article-title":"Defective autophagy in spastizin mutated patients with hereditary spastic paraparesis type 15","volume":"136","author":"Vantaggiato","year":"2013","journal-title":"Brain"},{"issue":"2","key":"10.1016\/j.parkreldis.2017.02.025_bib7","doi-asserted-by":"crossref","first-page":"E376","DOI":"10.1002\/humu.20920","article-title":"Complicated forms of autosomal dominant hereditary spastic paraplegia are frequent in SPG10","volume":"30","author":"Goizet","year":"2009","journal-title":"Hum. Mutat."},{"issue":"2","key":"10.1016\/j.parkreldis.2017.02.025_bib8","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1111\/j.1468-1331.2012.03803.x","article-title":"Novel SPG10 mutation associated with dysautonomia, spinal cord atrophy, and skin biopsy abnormality","volume":"20","author":"Collongues","year":"2013","journal-title":"Eur. J. Neurol."},{"issue":"10","key":"10.1016\/j.parkreldis.2017.02.025_bib9","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1016\/j.yexcr.2007.03.011","article-title":"New movements in neurofilament transport, turnover and disease","volume":"313","author":"Barry","year":"2007","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.parkreldis.2017.02.025_bib10","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1212\/01.wnl.0000338144.10967.2b","article-title":"FBXO7 mutations cause autosomal recessive, early-onset parkinsonian-pyramidal syndrome","volume":"72","author":"Di Fonzo","year":"2009","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/j.parkreldis.2017.02.025_bib11","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1002\/mds.23221","article-title":"Early-onset L-dopa-responsive parkinsonism with pyramidal signs due to ATP13A2,PLA2G6, FBXO7 and spatacsin mutations","volume":"25","author":"Pais\u00e1n-Ruiz","year":"2010","journal-title":"Mov. Disord."},{"issue":"1","key":"10.1016\/j.parkreldis.2017.02.025_bib12","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1001\/jamaneurol.2013.572","article-title":"F-box only protein 7 gene in parkinsonian-pyramidal disease","volume":"70","author":"Deng","year":"2013","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.parkreldis.2017.02.025_bib13","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1002\/mds.26266","article-title":"A\u00a0new F-box protein 7 gene mutation causing typical Parkinson's disease","volume":"30","author":"Lohmann","year":"2015","journal-title":"Mov. Disord."},{"issue":"22","key":"10.1016\/j.parkreldis.2017.02.025_bib14","doi-asserted-by":"crossref","first-page":"6314","DOI":"10.1093\/hmg\/ddv340","article-title":"F-box protein 7 mutations promote protein aggregation in mitochondria and inhibit mitophagy","volume":"24","author":"Zhou","year":"2015","journal-title":"Hum. Mol. Genet."},{"issue":"6","key":"10.1016\/j.parkreldis.2017.02.025_bib15","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1002\/mds.26243","article-title":"The role of ATP13A2 in Parkinson's disease: clinical phenotypes and molecular mechanisms","volume":"30","author":"Park","year":"2015","journal-title":"Mov. Disord."},{"issue":"3","key":"10.1016\/j.parkreldis.2017.02.025_bib16","doi-asserted-by":"crossref","first-page":"407","DOI":"10.3174\/ajnr.A2677","article-title":"Neuroimaging features of neurodegeneration with brain iron accumulation","volume":"33","author":"Kruer","year":"2012","journal-title":"Am. J. Neuroradiol."},{"issue":"12","key":"10.1016\/j.parkreldis.2017.02.025_bib17","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.1093\/hmg\/dds089","article-title":"Mutation of the parkinsonism gene ATP13A2 causes neuronal ceroid-lipofuscinosis","volume":"21","author":"Bras","year":"2012","journal-title":"Hum. Mol. Genet."},{"issue":"3","key":"10.1016\/j.parkreldis.2017.02.025_bib18","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.nbd.2011.02.009","article-title":"Katz MLA truncating mutation in ATP13A2 is responsible for adult-onset neuronal ceroid lipofuscinosis in Tibetan terriers","volume":"42","author":"Farias","year":"2011","journal-title":"Neurobiol. Dis."},{"issue":"15","key":"10.1016\/j.parkreldis.2017.02.025_bib19","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1212\/WNL.0b013e3181f73649","article-title":"Phenotypic spectrum of patients with PLA2G6 mutation and PARK14-linked parkinsonism","volume":"75","author":"Yoshino","year":"2010","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.parkreldis.2017.02.025_bib20","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/ajmg.b.32012","article-title":"PLA2G6 mutations in PARK14-linked young-onset parkinsonism and sporadic Parkinson's disease","volume":"159B","author":"Lu","year":"2012","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"issue":"7","key":"10.1016\/j.parkreldis.2017.02.025_bib21","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1093\/brain\/awv132","article-title":"Loss of PLA2G6 leads to elevated mitochondrial lipid peroxidation and mitochondrial dysfunction","volume":"138","author":"Kinghorn","year":"2015","journal-title":"Brain"},{"key":"10.1016\/j.parkreldis.2017.02.025_bib22","doi-asserted-by":"crossref","first-page":"e36458","DOI":"10.1371\/journal.pone.0036458","article-title":"A\u00a0deleterious mutation in DNAJC6 encoding the neuronal-specific clathrin- uncoating co-chaperone auxilin, is associated with juvenile parkinsonism","volume":"7","author":"Edvardson","year":"2012","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.parkreldis.2017.02.025_bib23","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.parkreldis.2012.11.006","article-title":"DNAJC6 is responsible for juvenile parkinsonism with phenotypic variability","volume":"19","author":"K\u00f6ro\u011flu","year":"2013","journal-title":"Park. Relat. Disord."},{"issue":"3","key":"10.1016\/j.parkreldis.2017.02.025_bib24","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.ajhg.2016.01.014","article-title":"French Parkinson's disease genetics study (PDG) loss of VPS13C function in autosomal-recessive parkinsonism causes mitochondrial dysfunction and increases PINK1\/parkin-dependent mitophagy","volume":"98","author":"Lesage","year":"2016","journal-title":"Am. J. Hum. Genet."},{"issue":"16","key":"10.1016\/j.parkreldis.2017.02.025_bib25","doi-asserted-by":"crossref","first-page":"3259","DOI":"10.1093\/hmg\/ddt180","article-title":"Altered splicing of ATP6AP2 causes X-linked parkinsonism with spasticity (XPDS)","volume":"22","author":"Korvatska","year":"2013","journal-title":"Hum. Mol. Genet."},{"issue":"10","key":"10.1016\/j.parkreldis.2017.02.025_bib26","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1002\/mds.23085","article-title":"A\u00a0novel X-linked four-repeat tauopathy with Parkinsonism and spasticity","volume":"25","author":"Poorkaj","year":"2010","journal-title":"Mov. Disord."},{"issue":"4","key":"10.1016\/j.parkreldis.2017.02.025_bib27","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/ana.23894","article-title":"French Parkinson's Disease Genetics Study Group. G51D \u03b1-synuclein mutation causes a novel parkinsonian-pyramidal syndrome","volume":"73","author":"Lesage","year":"2013","journal-title":"Ann. Neurol."},{"issue":"6","key":"10.1016\/j.parkreldis.2017.02.025_bib28","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1111\/jnc.12806","article-title":"Divergent effects of the H50Q and G51D SNCA mutations on the aggregation of \u03b1-synuclein","volume":"131","author":"Rutherford","year":"2014","journal-title":"J.\u00a0Neurochem."},{"issue":"1","key":"10.1016\/j.parkreldis.2017.02.025_bib29","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/mds.23971","article-title":"Syndromes of neurodegeneration with brain iron accumulation (NBIA): an update on clinical presentations, histological and genetic underpinnings, and treatment considerations","volume":"27","author":"Schneider","year":"2012","journal-title":"Mov. Disord."},{"issue":"1","key":"10.1016\/j.parkreldis.2017.02.025_bib30","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/mds.10650","article-title":"Clinical heterogeneity of neurodegeneration with brain iron accumulation (Hallervorden-Spatz syndrome) and pantothenate kinase-associated neurodegeneration","volume":"19","author":"Thomas","year":"2004","journal-title":"Mov. Disord."},{"issue":"3","key":"10.1016\/j.parkreldis.2017.02.025_bib31","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1093\/hmg\/ddg026","article-title":"An isoform of hPANK2, deficient in pantothenate kinase-associated neurodegeneration, localizes to mitochondria","volume":"12","author":"H\u00f6rtnagel","year":"2003","journal-title":"Hum. Mol. Genet."},{"issue":"3","key":"10.1016\/j.parkreldis.2017.02.025_bib32","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1212\/WNL.0b013e31827e07be","article-title":"New NBIA subtype: genetic, clinical, pathologic, and radiographic features of MPAN","volume":"80","author":"Hogarth","year":"2013","journal-title":"Neurology"},{"issue":"10","key":"10.1016\/j.parkreldis.2017.02.025_bib33","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1002\/humu.22378","article-title":"Hereditary spastic paraplegia type 43 (SPG43) is caused by mutation in C19orf12","volume":"34","author":"Landour\u00e9","year":"2013","journal-title":"Hum. Mutat."},{"issue":"3","key":"10.1016\/j.parkreldis.2017.02.025_bib34","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/nan.12242","article-title":"Insights into molecular mechanisms of disease in neurodegeneration with brain iron accumulation: unifying theories","volume":"42","author":"Arber","year":"2016","journal-title":"Neuropathol. Appl. Neurobiol."},{"issue":"1","key":"10.1016\/j.parkreldis.2017.02.025_bib35","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1093\/brain\/awl319","article-title":"Clinical features and natural history of neuroferritinopathy caused by the FTL1 460InsA mutation","volume":"130","author":"Chinnery","year":"2007","journal-title":"Brain"},{"issue":"3","key":"10.1016\/j.parkreldis.2017.02.025_bib36","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.parkreldis.2013.11.019","article-title":"Beta-propeller protein-associated neurodegeneration (BPAN), a rare form of NBIA: novel mutations and neuropsychiatric phenotype in three adult patients","volume":"20","author":"Verhoeven","year":"2014","journal-title":"Park. Relat. Disord."},{"issue":"5","key":"10.1016\/j.parkreldis.2017.02.025_bib37","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1212\/WNL.54.5.1069","article-title":"Decreased striatal DopamineTransporter density in JNCL patients with parkinsonian symptoms","volume":"54","author":"Aberg","year":"2000","journal-title":"Neurology"},{"issue":"1\u20132","key":"10.1016\/j.parkreldis.2017.02.025_bib38","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jns.2015.05.021","article-title":"Protracted late infantile ceroid lipofuscinosis due to TPP1 mutations: clinical, molecular and biochemical characterization in three sibs","volume":"356","author":"Di Giacopo","year":"2015","journal-title":"J.\u00a0Neurol. Sci."},{"issue":"10","key":"10.1016\/j.parkreldis.2017.02.025_bib39","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1002\/mds.20593","article-title":"Dystonia and parkinsonism in GM1 type 3 gangliosidosis","volume":"20","author":"Roze","year":"2005","journal-title":"Mov. Disord."},{"issue":"5","key":"10.1016\/j.parkreldis.2017.02.025_bib40","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1136\/jnnp.65.5.788","article-title":"Adult polyglucosan body disease associated with an extrapyramidal syndrome","volume":"65","author":"Robertson","year":"1998","journal-title":"J.\u00a0Neurol. Neurosurg. Psychiatry"},{"issue":"5","key":"10.1016\/j.parkreldis.2017.02.025_bib41","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1002\/mds.23651","article-title":"Parkinson's syndrome and Parkinson's disease in mitochondrial disorders","volume":"26","author":"Finsterer","year":"2011","journal-title":"Mov. Disord."},{"issue":"Pt 4","key":"10.1016\/j.parkreldis.2017.02.025_bib42","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1093\/brain\/awu022","article-title":"Dopamine transporter deficiency syndrome: phenotypic spectrum from infancy to adulthood","volume":"137","author":"Ng","year":"2014","journal-title":"Brain"},{"issue":"7","key":"10.1016\/j.parkreldis.2017.02.025_bib43","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1002\/mds.23629","article-title":"Movement disorders in adult surviving patients with maple syrup urine disease","volume":"26","author":"Carecchio","year":"2011","journal-title":"Mov. Disord."},{"issue":"12","key":"10.1016\/j.parkreldis.2017.02.025_bib44","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1002\/mds.21170","article-title":"Neurological manifestations in Wilson's disease: report of 119 cases","volume":"21","author":"Machado","year":"2006","journal-title":"Mov. Disord."},{"issue":"3","key":"10.1016\/j.parkreldis.2017.02.025_bib45","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.ajhg.2012.01.017","article-title":"Mutations in SLC30A10 cause parkinsonism and dystonia with hypermanganesemia, polycythemia, and chronic liver disease","volume":"90","author":"Quadri","year":"2012","journal-title":"Am. J. Hum. Genet."},{"issue":"4","key":"10.1016\/j.parkreldis.2017.02.025_bib46","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1002\/mds.22979","article-title":"Cerebrotendinous xanthomatosis patients with and without parkinsonism: clinical characteristics and neuroimaging findings","volume":"25","author":"Su","year":"2010","journal-title":"Mov. Disord."},{"issue":"4","key":"10.1016\/j.parkreldis.2017.02.025_bib47","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s10545-009-9009-6","article-title":"Neuronopathic gaucher disease: demographic and clinical features of 131 patients enrolled in the international collaborative gaucher group neurological outcomes subregistry","volume":"33","author":"Tylki-Szyma\u0144ska","year":"2010","journal-title":"J.\u00a0Inherit. Metab. Dis."},{"issue":"1","key":"10.1016\/j.parkreldis.2017.02.025_bib48","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1093\/brain\/awl260","article-title":"The adult form of Niemann-Pick disease type C","volume":"130","author":"S\u00e9vin","year":"2007","journal-title":"Brain"},{"issue":"9","key":"10.1016\/j.parkreldis.2017.02.025_bib49","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S1474-4422(07)70194-1","article-title":"Miglustat for treatment of Niemann-Pick C disease: a randomised controlled study","volume":"6","author":"Patterson","year":"2007","journal-title":"Lancet Neurol."},{"issue":"7","key":"10.1016\/j.parkreldis.2017.02.025_bib50","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1002\/ajmg.b.32336","article-title":"Brain calcification process and phenotypes according to age and sex: lessons from SLC20A2, PDGFB, and PDGFRB mutation carriers","volume":"68","author":"Nicolas","year":"2015","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"issue":"6","key":"10.1016\/j.parkreldis.2017.02.025_bib51","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/ng.3289","article-title":"Mutations in XPR1 cause primary familial brain calcification associated with altered phosphate export","volume":"47","author":"Legati","year":"2015","journal-title":"Nat. Genet."},{"key":"10.1016\/j.parkreldis.2017.02.025_bib52","first-page":"125273","article-title":"Parkinsonism in spinocerebellar ataxia","author":"Park","year":"2015","journal-title":"Biomed. Res. Int."},{"issue":"2","key":"10.1016\/j.parkreldis.2017.02.025_bib53","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/s00439-005-0020-1","article-title":"EUROCJD. Genetic prion disease: the EUROCJD experience","volume":"118","author":"Kov\u00e1cs","year":"2005","journal-title":"Hum. Genet."},{"issue":"18","key":"10.1016\/j.parkreldis.2017.02.025_bib54","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1212\/WNL.0b013e318271f7ff","article-title":"FXTAS: new insights and the need for revised diagnostic criteria","volume":"79","author":"Apartis","year":"2012","journal-title":"Neurology"},{"issue":"10","key":"10.1016\/j.parkreldis.2017.02.025_bib55","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.parkreldis.2013.05.013","article-title":"Parkinsonian features in hereditary diffuse leukoencephalopathy with spheroids (HDLS) and CSF1R mutations","volume":"19","author":"Sundal","year":"2013","journal-title":"Park. Relat. Disord."},{"issue":"Pt 3","key":"10.1016\/j.parkreldis.2017.02.025_bib56","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1093\/brain\/aws004","article-title":"Characterization of frontotemporal dementia and\/or amyotrophic lateral sclerosis associated with the GGGGCC repeat expansion in C9ORF72","volume":"135","author":"Boeve","year":"2012","journal-title":"Brain"},{"issue":"3","key":"10.1016\/j.parkreldis.2017.02.025_bib57","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1056\/NEJMoa1212115","article-title":"Mutations in COQ2 in familial and sporadic multiple system atrophy","volume":"369","year":"2013","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.parkreldis.2017.02.025_bib58","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/S1474-4422(09)70042-0","article-title":"Progressive supranuclear palsy: clinicopathological concepts and diagnostic challenges","volume":"8","author":"Williams","year":"2009","journal-title":"Lancet Neurol."},{"issue":"5","key":"10.1016\/j.parkreldis.2017.02.025_bib59","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1212\/WNL.0b013e31827f0fd1","article-title":"Criteria for the diagnosis of corticobasal degeneration","volume":"80","author":"Armstrong","year":"2013","journal-title":"Neurology"},{"issue":"1\u20132","key":"10.1016\/j.parkreldis.2017.02.025_bib60","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.jns.2006.05.026","article-title":"Vascular parkinsonism\u2013an update","volume":"248","author":"Rektor","year":"2006","journal-title":"J.\u00a0Neurol. Sci."},{"key":"10.1016\/j.parkreldis.2017.02.025_bib61","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/S1474-4422(12)70063-7","article-title":"Sporadic human prion diseases: molecular insights and diagnosis","volume":"11","author":"Puoti","year":"2012","journal-title":"Lancet Neurol."},{"issue":"3","key":"10.1016\/j.parkreldis.2017.02.025_bib62","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1093\/brain\/awq022","article-title":"Dystonia in neurodegeneration with brain iron accumulation: outcome of bilateral pallidal stimulation","volume":"133","author":"Timmermann","year":"2010","journal-title":"Brain"},{"issue":"4","key":"10.1016\/j.parkreldis.2017.02.025_bib63","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1152\/physrev.00022.2010","article-title":"What genetics tells us about the causes and mechanisms of Parkinson's disease","volume":"91","author":"Corti","year":"2011","journal-title":"Physiol. Rev."},{"issue":"1","key":"10.1016\/j.parkreldis.2017.02.025_bib64","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/nrn2946","article-title":"Hereditary spastic paraplegias: membrane traffic and the motor pathway","volume":"12","author":"Blackstone","year":"2011","journal-title":"Nat. Rev. Neurosci."}],"container-title":["Parkinsonism & Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802017300755?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802017300755?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,3]],"date-time":"2018-09-03T23:55:13Z","timestamp":1536018913000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1353802017300755"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":64,"alternative-id":["S1353802017300755"],"URL":"https:\/\/doi.org\/10.1016\/j.parkreldis.2017.02.025","relation":{},"ISSN":["1353-8020"],"issn-type":[{"value":"1353-8020","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Parkinsonian-Pyramidal syndromes: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Parkinsonism & Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.parkreldis.2017.02.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}